• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Cyclical·AMMJ
Share

American Cannabis Company, Inc. Stocks

$ 0Last Updated 23.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 55740

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

American Cannabis Company, Inc., operating alongside its subsidiary Hollister & Blacksmith, Inc., delivers comprehensive solutions to companies engaged in the regulated cannabis industry across both the United States and Canada. The company's offerings encompass a broad range of consulting services, supporting cannabis and hemp enterprises through various developmental phases. These include strategic business planning, navigating license applications, formulating growth strategies, and continuous operational monitoring. Additionally, they provide expert oversight for cultivation facility build-outs, ensure adherence to cannabis regulatory frameworks, and conduct thorough compliance audits. ACC also offers specialized advisory services for designing industry-specific products and facilities, and it manages a collaborative partnership that supplies commonly utilized products to the sector. Furthermore, American Cannabis Company markets a variety of products and equipment essential for the cultivation, processing, transportation, and retail sale of cannabis. Key examples from their product line feature "The Satchel," a child-proof exit packaging solution tailored for regulated cannabis sales; "SoHum Living Soil," a convenient just-add-water growing medium; a "High Density Cultivation System" designed to optimize space utilization; and "The Cultivation Cube," a scalable, self-contained cultivation unit. Their inventory also extends to other products vital for general cultivation activities, operations of both medicinal and recreational cannabis dispensaries, and the creation of infused cannabis products. Founded in 2013, American Cannabis Company, Inc. maintains its corporate headquarters in Denver, Colorado.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026